Clinical Trials
4 trialsNCT03267030 2024-03-15
Asparaginase Encapsulated in Erythrocytes for Patients With ALL and Hypersensitivity to PEG-asparaginase
Aarhus University Hospital
Phase 2 Completed
NCT01810705 2022-02-21
ENFORCE
ERYtech Pharma
Phase 2 Completed
NCT02197650 2018-12-04
EAP
ERYtech Pharma
No longer available
NCT01910428 2018-07-05
L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL
ERYtech Pharma
Phase 1 Terminated